Stocks discussed in the in-depth session of Jim Cramer’s Mad Money TV program, Friday June 1. Click on a stock ticker for more analysis:
Seeking Alpha publishes a summary of Jim Cramer's stock picks every day including: Mad Money Recap, Lightning Round, Stop Trading and his Wall Street Confidential Picks.
Cramer confesses his pick this speculation Friday isn't such a wild speculation, since it seems obvious NVT will be bought out by someone. "This $4 billion company, the No. 1 supplier of digital maps used in navigation systems, location-based services and geographic information systems, has been acting like deal bait," he said. Rumors that Google will buy NVT have brought up the stock, and when this happens, a stock usually does not drop even if the rumored acquisition doesn't take place, notes Cramer. However, Google has already indicated its interest in buying NVT, and MSFT, desperate to compete with the internet giant, might also make a bid. "Takeovers aside, Navteq is the big winner from the increased demand for in-car navigation," Cramer said.
Related: Tiernan Ray comments on NVT's rise on LBO speculation.
Cramer introduced Limelight Networks, a "top-notch steaming, steaming-hot IPO" which will be buoyed up by hype that it might be the next Akamai, which is "tapped out." While he doesn't think Limelight will be as strong a company as Akamai and notes MIT and Akamai are suing the new IPO, Cramer would buy the stock for the hype and suggests picking it up from $10 to $17 and selling it at $23. He reminded viewers that he's sticking with LVLT; "I like it more than ever."
While Trimble is "Ok" and is a potential takeover target, Cramer says its a "little bit second-rate vs. Garmin."
Related: Faisal Laljee discusses GRMN's "fabulous" earnings report in May.
Game Plan for the Coming Week: Onyx Pharmaceutical (NASDAQ:ONXX), PDL BioPharma (NASDAQ:PDLI), Norfolk Southern (NYSE:NCS), Chemical & Mining Co. of Chile (NYSE:SQM), Monsanto (NYSE:MON), Johnson & Johnson (NYSE:JNJ), NYSE Euronext (NYSE:NYX)
The upcoming week is conference week, and Cramer expects " serious good news" on liver cancer treatment from ONXX at the ASCO (American Society of Clinical Oncology). He thinks the company will be "hard-pressed to stay independent," and he would buy ONXX on Monday ahead of Tuesday's conference. PDLI might attract even more attention, at least from hedge funds, and may gain up to 5 points. Since the "Norfolk Southern guys are cautious" Cramer would buy ahead of its June 6th meeting and sell on the day. He finds it hard to believe the agricultural sector could go even higher on Tuesday's Merrill Lynch conference on fertilizer and seed, but "anything is possible in a bull market" and he likes SQM and MON. Cramer may be the only one who is not expecting good news at the Johnson & Johnson conference on Tuesday, since it has so much competition and so many drugs going off patent. While Cramer admits NYX is "truly hated," he believes it is going higher and adds, "If you think I'm wrong on New York Stock Exchange Euronext, put your money where your mouth is."
Related: Ant & Sons observe that NYX's decline seems immune to analyst upgrades.
CEO Interview: Sally Smith, Buffalo Wild Wings (NASDAQ:BWLD)
Cramer thanked Sally Smith for "making so many of our viewers so much money" and commented BWLD's conference call was one of the best this quarter. On plans to open a new store at Ohio State, Smith said, "It's two touchdown passes from the stadium. It's two levels and will seat 350 people." When Cramer asked why many college campuses still do not have a Buffalo Wild Wings stores, Smith replied, "As we go in and build out markets, undoubtedly we will be locating by those college campuses. They make some of our best fans."
Get Cramer's Picks by e-mail -- it's free and takes only a few seconds to sign up.
Seeking Alpha is not affiliated with Jim Cramer, CNBC or TheStreet.com